Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Current Oncology Reports|December 21, 2000
Biomarkers as surrogates for cancer developmentE Hawk, J L Viner, J A LawrenceAnnals of the New York Academy of Sciences|January 25, 2002
The future of colon cancer preventionA Umar, J L Viner, E T HawkProceedings of the National Academy of Sciences of the United States of America|January 22, 1998
Isolation of a high-affinity stable single-chain Fv specific for mesothelin from DNA-immunized mice by phage display and construction of a recombinant immunotoxin with anti-tumor activityP S Chowdhury, J L Viner, R Beers, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Recommendations for cancer prevention trials using potentially ototoxic test agentsL I Shotland, F G Ondrey, K A Mayo, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 5, 2000
Anti-tumor activity of K1-LysPE38QQR, an immunotoxin targeting mesothelin, a cell-surface antigen overexpressed in ovarian cancer and malignant mesotheliomaR Hassan, J L Viner, Q C Wang, et al.International Journal of Oncology|September 21, 2000
Site-specific expression of transferrin receptor by human colon cancer cells directly correlates with eradication by antitransferrin recombinant immunotoxinH Shinohara, D Fan, S Ozawa, et al.The Journal of Nutrition|March 18, 2000
Progress in cancer chemoprevention: development of diet-derived chemopreventive agentsG J Kelloff, J A Crowell, V E Steele, et al.Annals of the New York Academy of Sciences|February 11, 2000
Progress in cancer chemopreventionG J Kelloff, J A Crowell, V E Steele, et al.Pageof 1